Treating agent for endothelial dysfunction

WO2026010464A1PCT designated stage Publication Date: 2026-01-08CURACLE CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2025/009719
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-07-03
Filing Date
2025-07-07
Publication Date
2026-01-08

Smart Images

  • Figure KR2025009719_08012026_PF_FP_ABST
    Figure KR2025009719_08012026_PF_FP_ABST
Patent Text Reader

Abstract

Compounds represented by chemical formulae IA, IB, IC, ID, IE, IF, IG, IH or IJ, according to the present invention, are useful for endothelial dysfunction or vascular leakage diseases. [Formula I]
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Vascular leakage inhibitor

    US8889840B2

  • Vascular leakage inhibitor

    US9353144B2

  • New 17-iminomethylalkenyl-5beta-14beta-androstane and 17-iminoalkyl-5beta-14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same

    EP0659761B1

  • Composition having ginsenosides for treating orpreventing angiostenosis and restenosis

    KR1020050117787A

  • Novel Blocker for Vascular Leakage

    KR1020110047170A